申请人:Brandeis University
公开号:US10711261B2
公开(公告)日:2020-07-14
Described herein are compounds and methods for tethering proteins. For example, dimers of Protein X listed in Table 1 are described, where the dimers are formed by the covalent bonding of a cysteine on the first monomer to a cysteine on the second monomer via a cyclic disulfide linker. The covalently attached dimers exhibit increased stabilization and can be used to treat neurodegenerative diseases (such as, for example, Parkinson's Disease, ALS, Alzheimer's Disease, Huntington's Disease, Epilepsy, Frontotemporal Dementia, and/or DMD), cancer, autoimmune disease, and/or Celiac disease.
本文描述了用于系链蛋白质的化合物和方法。例如,描述了表 1 所列蛋白质 X 的二聚体,其中二聚体是通过环状二硫连接体将第一单体上的半胱氨酸与第二单体上的半胱氨酸共价键合而形成的。共价连接的二聚体具有更高的稳定性,可用于治疗神经退行性疾病(例如帕金森病、渐冻人症、阿尔茨海默病、亨廷顿氏病、癫痫、额颞叶痴呆和/或 DMD)、癌症、自身免疫性疾病和/或乳糜泻。